LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. (Record no. 29732602)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01264 a2200325 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518042017.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201907s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1699-3993 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1358/dot.2019.55.5.2976501 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sabatel-Pérez, F |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190731 |
245 00 - TITLE STATEMENT | |
Title | LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Drugs of today (Barcelona, Spain : 1998) |
Date of publication, distribution, etc. | May 2019 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 329-344 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticholesteremic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Atherosclerosis |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cardiovascular Diseases |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cholesterol, LDL |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | PCSK9 Inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Subtilisins |
General subdivision | antagonists & inhibitors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | García-Ropero, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Santos-Gallego, C G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Urooj Zafar, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Badimón, J J |
773 0# - HOST ITEM ENTRY | |
Title | Drugs of today (Barcelona, Spain : 1998) |
Related parts | vol. 55 |
-- | no. 5 |
-- | p. 329-344 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1358/dot.2019.55.5.2976501">https://doi.org/10.1358/dot.2019.55.5.2976501</a> |
Public note | Available from publisher's website |
No items available.